HERVolution Appoints Dr. Tine Gaziel as CMO to Advance Dark Genome-Targeting Immune Therapy into the Clinic
As an experienced and thoughtful medical executive, Dr. Gaziel directed key clinical development and research at Eli Lilly, Y-mAbs Therapeutics, and Genmab